Table 1.

Demographic characteristics and comorbidities of COVID-19 patients with pulmonary fibrosis.

Variables	Overall (N = 64)	Survived (N = 32)	Deceased (N = 32)	P
Age
23–45	7 (10.9%)	5 (15.6%)	2 (6.2%)	.204
46–64	35 (54.7%)	19 (59.4%)	16 (50.0%)
65–89	22 (34.4%)	8 (25.0%)	14 (43.8%)
Sex
Male	46 (71.9%)	26 (81.2%)	20 (62.5%)	.095
Female	18 (28.1%)	6 (18.8%)	12 (37.5%)
Smoking
Non-smoker	40 (66.7%)	28 (87.5%)	12 (37.5%)	<.001∗
X-smoker	8 (13.3%)	0	8 (25.0%)
Smoker	12 (20.0)	4 (12.5%)	12 (37.5%)
Diabetes
No	22 (34.4%)	12 (37.5%)	10 (31.2%)	.599
Yes	42 (65.6%)	20 (62.5%)	22 (68.8%)
Hypertension
No	22 (34.4%)	12 (37.5%)	10 (31.2%)	.599
Yes	42 (65.6%)	20 (62.5%)	22 (68.8%)
Obesity
No	37 (57.8%)	19 (59.4%)	18 (56.2%)	.802
Yes	27 (42.2%)	13 (40.6%)	14 (43.8%)
Heart disease
No	58 (90.6%)	28 (87.5%)	30 (93.8%)	.391
Yes	6 (9.4%)	4 (12.5%)	2 (6.2%)
Kidney disease
No	62 (96.9%)	32 (100.0%)	30 (93.8%)	.151
Yes	2 (3.1%)	0	2 (6.2%)
Asthma
No	54 (84.4%)	32 (100.0%)	22 (68.8%)	.001∗
Yes	10 (15.6%)	0	10 (31.2%)
Tuberculosis
No	63 (98.4%)	31 (96.9%)	32 (100.0%)	.313
Yes	1 (1.6%)	1 (3.1%)	0
COPD†
No	63 (98.4%)	31 (96.9%)	32 (100.0%)	.313
Yes	1 (1.6%)	1 (3.1%)	0